Cargando…

ADAM12 promotes clear cell renal cell carcinoma progression and triggers EMT via EGFR/ERK signaling pathway

BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a major worldwide health problem due to its high prevalence and mortality rate. A disintegrin and metalloproteinase 12 (ADAM12) is aberrantly expressed in various cancers and plays an important role in tumor progression. However, its explicit ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinming, Wang, Yan, Jiang, Jiahao, Yin, Cong, Shi, Bentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885678/ https://www.ncbi.nlm.nih.gov/pubmed/36717944 http://dx.doi.org/10.1186/s12967-023-03913-1

Ejemplares similares

Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis
por: Xu, Jinming, et al.
Publicado: (2023)

Renal pseudoaneurysm after holmium laser lithotripsy with flexible ureteroscopy: an unusual case report and literature review
por: Yin, Cong, et al.
Publicado: (2023)

ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma
por: Gao, Junjie, et al.
Publicado: (2022)

TNFAIP8 promotes the migration of clear cell renal cell carcinoma by regulating the EMT
por: Zhong, Mengya, et al.
Publicado: (2020)

ADAM metalloproteases and EGFR signalling
por: Gee, Julia MW, et al.
Publicado: (2003)

MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria‐dependent dephosphorylation of EGFR
por: Luo, Li, et al.
Publicado: (2023)

Renal Arteries Embolization in Unresectable Clear Cell Renal Carcinoma: First Time Experience at Haji Adam Malik Hospital
por: Perdana, Noor Riza, et al.
Publicado: (2018)

Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway
por: Sheng, Weiwei, et al.
Publicado: (2017)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation
por: Yang, Wuping, et al.
Publicado: (2023)

Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh-7 cells by regulating the ERK-VEGF/MMP9 signaling pathway
por: Chen, Yafei, et al.
Publicado: (2019)

MiR-338-5p Inhibits EGF-Induced EMT in Pancreatic Cancer Cells by Targeting EGFR/ERK Signaling
por: Sun, Jian, et al.
Publicado: (2021)

Integrating bioinformatic analysis and detailed experiments reveal an EMT‐related biomarker for clear cell renal cell carcinoma
por: Ge, Yue, et al.
Publicado: (2023)

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth
por: Allahverdi, Amir, et al.
Publicado: (2020)

Fisetin Suppresses the Proliferation and Metastasis of Renal Cell Carcinoma through Upregulation of MEK/ERK-Targeting CTSS and ADAM9
por: Hsieh, Min-Hong, et al.
Publicado: (2019)

Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT
por: Kang, Xing, et al.
Publicado: (2021)

Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands
por: Sahin, Umut, et al.
Publicado: (2004)

MTDH promotes metastasis of clear cell renal cell carcinoma by activating SND1-mediated ERK signaling and epithelial-mesenchymal transition
por: He, Anbang, et al.
Publicado: (2020)

A Bispecific Inhibitor of the EGFR/ADAM17 Axis Decreases Cell Proliferation and Migration of EGFR-Dependent Cancer Cells
por: Soto-Gamez, Abel, et al.
Publicado: (2020)

SLC17A9-PTHLH-EMT axis promotes proliferation and invasion of clear renal cell carcinoma
por: Li, Weiquan, et al.
Publicado: (2022)

Pomegranate extract inhibits EMT in clear cell renal cell carcinoma in a NF-κB and JNK dependent manner
por: An, Jiabin, et al.
Publicado: (2015)

Correction to: Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT
por: Kang, Xing, et al.
Publicado: (2021)

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation
por: Liu, Tao, et al.
Publicado: (2023)

Expression and clinical significance of PTPN12 in clear cell renal cell carcinoma
por: Jin, Yi, et al.
Publicado: (2020)

Cadherin-12 enhances proliferation in colorectal cancer cells and increases progression by promoting EMT
por: Ma, Junjun, et al.
Publicado: (2016)

PPARγ is dispensable for clear cell renal cell carcinoma progression
por: Sanchez, Danielle J., et al.
Publicado: (2018)

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma
por: Hu, Junhui, et al.
Publicado: (2019)

The ILEI/LIFR complex induces EMT via the Akt and ERK pathways in renal interstitial fibrosis
por: Zhou, Jieqing, et al.
Publicado: (2022)

Siglec-15 promotes progression of clear renal cell carcinoma
por: Yang, Wen-Bo, et al.
Publicado: (2021)

Immunological perspective on the malignant progression of renal clear cell carcinoma
por: Liu, Ji, et al.
Publicado: (2021)

RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway
por: Li, Mingyang, et al.
Publicado: (2021)

Circ-APBB1IP as a Prognostic Biomarker Promotes Clear Cell Renal Cell Carcinoma Progression Through The ERK1/2 Signaling Pathway
por: Mo, Jierong, et al.
Publicado: (2020)

Trim24 prompts tumor progression via inducing EMT in renal cell carcinoma
por: Jiang, Tao, et al.
Publicado: (2020)

Betulinic acid triggers apoptosis and inhibits migration and invasion of gastric cancer cells by impairing EMT progress
por: Chen, Yun, et al.
Publicado: (2020)

NCOA7 Regulates Growth and Metastasis of Clear Cell Renal Cell Carcinoma via MAPK/ERK Signaling Pathway
por: Guo, Jiayu, et al.
Publicado: (2023)

ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis
por: Zbodakova, Olga, et al.
Publicado: (2021)

Construction of EMT related prognostic signature for kidney renal clear cell carcinoma, through integrating bulk and single-cell gene expression profiles
por: Huang, Qi, et al.
Publicado: (2023)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

Glycogen metabolism is dispensable for tumor progression in clear cell renal cell carcinoma
por: Xie, Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5agvj8r8p5ponk434he00hh4dh